Panaccione R, Vermeire S, Danese S, Higgins PDR, et al. Long-term efficacy and safety of upadacitinib in patients with moderately to severely active ulcerative colitis: an interim analysis of the phase 3 U-ACTIVATE long-term extension study. Lancet Gastroenterol Hepatol 2025;10:507-519.
PMID: 40347957